Items related to Novel Developments in Stem Cell Mobilization: Focus...
Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.
"synopsis" may belong to another edition of this title.
- PublisherSpringer
- Publication date2012
- ISBN 10 146141959X
- ISBN 13 9781461419594
- BindingHardcover
- Number of pages512
- EditorFruehauf Stefan, Zeller W. Jens, Calandra Gary
Buy New
Learn more about this copy
£ 138.99
Shipping:
FREE
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Seller Image
Novel Developments in Stem Cell Mobilization: Focus on CXCR4 [Hardcover ]
Seller:
Rating
Book Description Hardcover. Condition: new. Seller Inventory # 9781461419594
Buy New
£ 138.99
Convert currency
Stock Image
Novel Developments in Stem Cell Mobilization : Focus on CXCR4
Published by
Springer
(2012)
ISBN 10: 146141959X
ISBN 13: 9781461419594
New
Hardcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9781461419594_lsuk
Buy New
£ 137.24
Convert currency
Stock Image
Novel Developments in Stem Cell Mobilization: Focus on CXCR4
Published by
Springer
(2012)
ISBN 10: 146141959X
ISBN 13: 9781461419594
New
Hardcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Mar2716030035478
Buy New
£ 147.57
Convert currency
Seller Image
Novel Developments in Stem Cell Mobilization
Published by
Springer New York Feb 2012
(2012)
ISBN 10: 146141959X
ISBN 13: 9781461419594
New
Hardcover
Quantity: 2
Seller:
Rating
Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented. 512 pp. Englisch. Seller Inventory # 9781461419594
Buy New
£ 142.19
Convert currency
Seller Image
Novel Developments in Stem Cell Mobilization
Published by
Springer New York
(2012)
ISBN 10: 146141959X
ISBN 13: 9781461419594
New
Hardcover
Quantity: > 20
Seller:
Rating
Book Description Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A concise review of the current status of knowledge and future developments of CXCR4 will be presented Contributors are internationally leaders in the field A comprehensive treatment of the subject with numerous color illustrationsR. Seller Inventory # 4197295
Buy New
£ 120.64
Convert currency
Seller Image
Novel Developments in Stem Cell Mobilization : Focus on CXCR4
Published by
Springer New York
(2012)
ISBN 10: 146141959X
ISBN 13: 9781461419594
New
Hardcover
Quantity: 1
Seller:
Rating
Book Description Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented. Seller Inventory # 9781461419594
Buy New
£ 145.33
Convert currency